Previous reports have highlighted the key role of CES1 in liver lipid metabolism and associated its alterations with obesity, hepatic steatosis, hyperlipidemia, and an increased risk of cardiovascular disease (38–40). This evidence concerns the gene CES1 and hyperlipidemia.